Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan · Delayed Price · Currency is TWD 49.90
+0.05 (0.10%)
At close: Apr 24, 2026
Puriblood Medical Market Cap
Puriblood Medical has a market cap or net worth of 710.08 million as of April 24, 2026. Its market cap has decreased by -51.08% in one year.
Market Cap
710.08M
Enterprise Value
684.11M
Revenue
117.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.90
Market Cap Chart
Since November 5, 2021, Puriblood Medical's market cap has decreased from 1.83B to 710.08M, a decrease of -61.17%. That is a compound annual growth rate of -19.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 710.08M | -30.69% |
| Dec 31, 2025 | 1.02B | -28.36% |
| Dec 31, 2024 | 1.43B | -10.67% |
| Dec 29, 2023 | 1.60B | -16.97% |
| Dec 27, 2022 | 1.93B | -16.36% |
| Dec 30, 2021 | 2.31B | 26.07% |
| Nov 5, 2021 | 1.83B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 233.46B |
| Caliway Biopharmaceuticals | 155.17B |
| Heron Neutron Medical | 62.93B |
| Lotus Pharmaceutical | 58.87B |
| AmCad BioMed | 778.99M |
| BioLASCO Taiwan | 755.55M |
| Sofiva Genomics | 725.54M |
| SynCore Biotechnology Co.,Ltd | 687.47M |